首頁 > 市場調查報告書 > 製藥

藥物開發人工智能人工智能藥物研發

藥物發現中的人工智慧市場：按治療領域、按應用、按地區 - 規模、份額、展望、機會分析，2023-2030 年

市場調查報告書

商品編碼

1350333

藥物發現中的人工智慧市場：按治療領域、按應用、按地區 - 規模、份額、展望、機會分析，2023-2030 年

Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月08日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2030 年，人工智慧在藥物發現領域的全球市場規模將達到 35.474 億美元，2023 年至 2030 年的複合年增長率為 5.7%。

報告範圍		報告詳細資料
基準年	2022	2023 年市場規模	美國：12.667億美元
過去的資料	2018年至2021年	預測期間	2023-2030
預測 2023-2030 年複合年增長率：	15.80%	2030年價值預測	35.474億美元

人工智慧（AI）是創造智慧機器，特別是智慧電腦程式的科學和工程。 AI技術幾乎可以應用於製藥科學的各個方面，包括藥物發現、藥物開發、藥物再利用、藥物代謝預測、藥物毒性分析、藥物生產率提高和臨床試驗。這些技術統稱為 AIDD（藥物發現人工智慧）。

市場動態：

市場進入者不斷增加的技術進步、產品研究、聯合研究、研發協議和其他無機成長策略將在預測期內增加全球人工智慧在藥物發現市場的成長，預計這將是主要因素。

例如，2023 年5 月16 日，Google Cloud 在Bio-IT 世界大會上宣布了兩款新的人工智慧驅動的Lifestyle 產品，以加速生物技術、製藥和上市公司的藥物發現和精準醫療。宣布了科學解決方案。標靶和先導物識別套件可幫助研究人員識別胺基酸功能並預測蛋白質結構。 Multiomics Suite 加速基因組數據的發現和解釋，並幫助公司設計精準治療方法。

本研究的主要特點

本報告詳細分析了用於藥物發現的全球人工智慧市場，並提供了以 2022 年為基準年的預測期（2023-2030 年）的市場規模和平均年增長率 (CAGR%)。。
它也揭示了各個細分市場的潛在收入機會，並為該市場提供了一系列有吸引力的投資建議。
它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
根據公司亮點、產品組合、主要亮點、財務表現和策略等參數，介紹全球人工智慧藥物發現市場的領先公司。
本研究涵蓋的主要公司包括 IBM Corporation (Ibm Watson Health)、Exscientia、GNS Healthcare、Alphabet, Inc. (DEEPMIND)、Benevolent AI、Biosymetrics、Euretos、Berg LLC.、Atomwise, Inc. 等。
此報告的見解使行銷人員和公司主管能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球藥物發現中的人工智慧市場報告針對該行業的各個利益相關者，例如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
透過用於分析全球人工智慧藥物發現市場的各種策略矩陣，將有助於利害關係人做出決策。

市場動態
- 降低藥物開發和勘探成本的需求日益增加
- 慢性病的增加支持個人化藥物的開發
- 醫療保健和藥物發現領域大數據和資訊的爆炸性增長
- 拓展人工智慧在醫療健康各領域的應用
影響分析
主要亮點
監管場景
產品發布/核准
PEST分析
波特的分析
合併/收購場景

第 4 章藥物發現中的人工智慧市場 - 冠狀病毒 (COVID-19) 大流行的影響

COVID-19 的流行病學
供給面與需求面分析
經濟影響

第五章藥物發現中的人工智慧市場：依治療領域劃分，2023-2030

腫瘤學
神經退化性疾病
心血管疾病
代謝性疾病
傳染病
其他

第 6 章藥物發現中的人工智慧市場，按應用劃分，2020-2030 年

藥物優化與再利用
臨床前研究
其他

第 7 章藥物發現中的人工智慧市場（按地區劃分，2023-2030 年）

北美
拉丁美洲
歐洲
亞太地區
中東
非洲

第八章競爭態勢

IBM Corporation（Ibm Watson Health）
Exscientia
GNS Healthcare
Alphabet, Inc.（DEEPMIND）
Benevolent AI
Biosymetrics
Euretos
Berg LLC.
Atomwise, Inc.

第 9 章

調查方法
關於出版商

簡介目錄

Product Code: CMI6125

The global artificial intelligence in drug discovery market was valued at US$ 1,016.1 Mn in 2022 and is forecast to reach a value of US$ 3,547.4 Mn by 2030 at a CAGR of 5.7% between 2023 and 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,266.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	15.80%	2030 Value Projection:	US$ 3,547.4 Mn

Artificial Intelligence in Drug Discovery Market - IMG1

The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).

Market Dynamics:

Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.

For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence in drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.

Detailed Segmentation:

Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space:
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Other
Global Artificial Intelligence in Drug Discovery Market, By Application:
- Drug Optimization & Repurposing
- Preclinical Testing
- Others
Global Artificial Intelligence in Drug Discovery Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- IBM Corporation (Ibm Watson Health)
- Exscientia
- GNS Healthcare
- Alphabet, Inc. (DEEPMIND)
- Benevolent AI
- Biosymetrics
- Euretos
- Berg LLC.
- Atomwise, Inc.

Market Dynamics
- Rising need to curb drug development and discovery costs
- Rising prevalence of chronic diseases supporting development of personalized drugs
- Big data and information explosion in healthcare and drug discovery
- Growing applications of AI in various healthcare areas
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Artificial Intelligence in Drug Discovery Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Neurodegenerative Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Metabolic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Artificial Intelligence in Drug Discovery Market, By Application, 2020-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Drug Optimization & Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Artificial Intelligence in Drug Discovery Market, By Geography, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)

8. Competitive Landscape

IBM Corporation (Ibm Watson Health)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exscientia
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GNS Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alphabet, Inc. (DEEPMIND)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Benevolent AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biosymetrics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Euretos
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Berg LLC.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Atomwise, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views